SPDR® S&P Biotech ETF (XBI)

Add to Watchlists
Create an Alert
68.92 +0.76  +1.12% NYSE Arca Mar 24, 12:00 Delayed 2m USD
View Full Chart
XBI Price Chart

XBI Key Stats

Expense Ratio 0.35%
Share Class Assets Under Management 3.077B
30-Day Average Daily Volume Upgrade
Net Asset Value 68.08
Discount or Premium to NAV 0.12%
Turnover Ratio 75.00

XBI Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M 1.55% 0.84% 13
3M 10.81% 10.10% 15
6M 0.09% 0.40% 59
1Y 46.99% 13.78% 1
3Y 9.51% 7.50% 11
5Y 22.95% 16.67% 2
As of March 23, 2017
Returns for periods of 1 year and above are annualized.

XBI Asset Allocation

Type % Net % Long % Short
Cash 0.00 0.00 0.00
Stock 99.72% 99.72% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.28% 0.28% 0.00
As of March 22, 2017

XBI Region Exposure

Americas 100.0%
North America 100.0%
Latin America 0.00
Greater Europe 0.00
United Kingdom 0.00
Europe Developed 0.00
Europe Emerging 0.00
Africa/Middle East 0.00
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of March 22, 2017
Region breakdown data is calculated by using the long position holdings of the portfolio.

XBI Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of March 22, 2017

XBI Stock Market Capitalization

Giant 9.73%
Large 11.82%
Medium 24.76%
Small 34.29%
Micro 19.40%
As of March 22, 2017

XBI Stock Style Exposure

Large Cap Value 0.00
Large Cap Blend 7.46%
Large Cap Growth 14.72%
Mid Cap Value 0.00
Mid Cap Blend 2.48%
Mid Cap Growth 23.01%
Small Cap Value 1.44%
Small Cap Blend 4.22%
Small Cap Growth 46.66%
As of March 22, 2017
View More Holdings

XBI Top 10 Holdings

Symbol Name % Weight Price % Chg
CLVS Clovis Oncology Inc 2.67% 70.85 +3.39%
CELG Celgene Corp 2.47% 123.86 +0.52%
GILD Gilead Sciences Inc 2.47% 67.65 +0.24%
ABBV AbbVie Inc 2.47% 66.02 +0.56%
BLUE bluebird bio Inc 2.42% 89.20 +2.59%
BIVV Bioverativ Inc 2.40% 50.55 +0.16%
VRTX Vertex Pharmaceuticals Inc 2.38% 90.42 +1.54%
BIIB Biogen Inc 2.36% 276.16 +0.27%
REGN Regeneron Pharmaceuticals Inc 2.36% 374.00 +2.46%
ACAD ACADIA Pharmaceuticals Inc 2.35% 34.52 +0.20%
As of March 22, 2017
Advertisement

XBI One Page Reports

XBI Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name SPDR State Street Global Advisors
Benchmark Index
S&P Biotechnology Select Industry TR USD
100.0%

XBI Manager Info

Name Tenure
Karl Schneider 2.26 yrs
Michael Feehily 5.26 yrs
Raymond Donofrio 0.08 yrs

XBI Net Fund Flows

1M 93.45M
3M -399.70M
6M 563.32M
YTD 103.33M
1Y 602.76M
3Y 1.184B
5Y 1.521B
10Y 1.929B
As of Feb. 28, 2017

XBI Risk Info

Beta (5Y) 1.450
Max Drawdown (All) 49.39%
Historical Sharpe (10Y) 0.7399
Historical Sortino (All) 0.9596
30-Day Rolling Volatility 26.69%
Daily Value at Risk (VaR) 1% (All) 4.90%
Monthly Value at Risk (VaR) 1% (All) 21.43%

XBI Fundamentals

Dividend Yield TTM (3-24-17) 0.17%
SEC Yield (3-22-17) 0.03%
Weighted Average PE Ratio --
Weighted Average Price to Sales Ratio 9.020
Weighted Average Price to Book Ratio 5.501
Weighted Median ROE -8.69%
Weighted Median ROA -18.60%
Forecasted Dividend Yield 0.27%
Forecasted PE Ratio 23.44
Forecasted Price to Sales Ratio 4.439
Forecasted Price to Book Ratio 4.324
Number of Holdings 95
As of March 22, 2017

XBI Growth Estimates

Forecasted 5 Yr Earnings Growth 23.51%
Forecasted Book Value Growth 11.26%
Forecasted Cash Flow Growth 23.97%
Forecasted Earnings Growth 10.60%
Forecasted Revenue Growth 24.23%
As of March 22, 2017

XBI Comparables

Edit

XBI Attributes

Key Dates
Inception Date 1/31/2006
Last Annual Report Date 6/30/2016
Last Prospectus Date 10/31/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan Yes
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

XBI Excel Add-In Codes

  • Name: =YCI("XBI","name")
  • Broad Asset Class: =YCI("XBI", "broad_asset_class")
  • Broad Category: =YCI("XBI", "broad_category_group")
  • Prospectus Objective: =YCI("XBI", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.